Source:http://linkedlifedata.com/resource/pubmed/id/10875615
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003241,
umls-concept:C0017968,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0332307,
umls-concept:C0439855,
umls-concept:C0871261,
umls-concept:C1332714,
umls-concept:C1514562,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1880389,
umls-concept:C1883204,
umls-concept:C1883221,
umls-concept:C2911692
|
pubmed:issue |
9
|
pubmed:dateCreated |
2000-7-25
|
pubmed:abstractText |
HIV-specific CD4+ helper T cell responses, particularly to the envelope glycoproteins, are usually weak or absent in the majority of HIV-seropositive individuals. Since antibodies, by their capacity to alter antigen uptake and processing, are known to have modulatory effects on CD4+ T cell responses, we investigated the effect of antibodies produced by HIV-infected individuals on the CD4+ T cell response to HIV-1 gp120. Proliferative responses of gp120-specific CD4+ T cells were inhibited in the presence of either serum immunoglobulin from HIV-infected individuals or human monoclonal antibodies specific for the CD4-binding domain (CD4bd) of gp120. Human monoclonal antibodies to other gp120 epitopes did not have the same effect. The anti-CD4bd antibodies complexed with gp120 suppressed T cell lines specific for varying gp120 epitopes but did not affect T cell proliferation to non-HIV antigens. Moreover, inhibition by the anti-CD4bd/gp120 complexes was observed regardless of the types of antigen-presenting cells used to stimulate the T cells. These results indicate that the presence of anti-CD4bd antibodies complexed with gp120 can strongly suppress CD4+ helper T responses to gp120.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigen-Antibody Complex,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Envelope Protein gp120
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0889-2229
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
893-905
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10875615-Amino Acid Sequence,
pubmed-meshheading:10875615-Antibodies, Monoclonal,
pubmed-meshheading:10875615-Antigen-Antibody Complex,
pubmed-meshheading:10875615-Antigen-Presenting Cells,
pubmed-meshheading:10875615-Antigens, Bacterial,
pubmed-meshheading:10875615-CD4-Positive T-Lymphocytes,
pubmed-meshheading:10875615-Cell Line,
pubmed-meshheading:10875615-Epitopes,
pubmed-meshheading:10875615-HIV Antibodies,
pubmed-meshheading:10875615-HIV Envelope Protein gp120,
pubmed-meshheading:10875615-Humans,
pubmed-meshheading:10875615-Lymphocyte Activation,
pubmed-meshheading:10875615-Mycobacterium tuberculosis
|
pubmed:year |
2000
|
pubmed:articleTitle |
Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120.
|
pubmed:affiliation |
New York Veteran Affairs Medical Center and Department of Pathology, New York University School of Medicine, New York 10010, USA. hioec01@med.nyu.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|